Rentschler Biopharma SE
June 22, 2026
Theater 4
Type: Company Presentation
Focus Area:
Contract Manufacturing Organization
Rentschler Biopharma is a global leading contract development and manufacturing organization (CDMO) focused exclusively on client projects. The company offers process development and manufacturing of biopharmaceuticals, as well as related consulting activities, project management and regulatory services.
Working collaboratively with its clients, Rentschler Biopharma provides customized solutions with optimized work packages for each development stage. State-of-the-art cGMP facilities and cell culture processes allow manufacturing for both clinical studies and commercial supply.
As a world-class solution provider, with over 50 years of experience in Biopharma, the company ensures optimum time-to-clinic and time-to-market by accelerating timelines to create a competitive advantage for clients. Rentschler Biopharma is family-owned with about 1,400 employees, headquartered in Laupheim, Germany, with operations in Milford, MA, USA. The company is part of the United Nations Global Compact.
Company HQ City:
Laupheim
Company HQ State:
Germany
Company HQ Country:
Germany
Year Founded:
1927
Lead Product in Development:
As a CDMO we develop and manufacture our clients´ products
CEO
Prof. Dr. Uwe Bücheler
Development Phase of Lead Product
Other/Not Applicable
When you expect your next catalyst update?
not applicable
What is your next catalyst (value inflection) update?
not applicable
Primary Speaker
)
)
)
){kind=logo}
){kind=logo}
)
)
){kind=logo}
){kind=logo}